Target intelligence / Profile preview

Capillary endothelial barrier

Molecular classification
Cell adhesion molecule, Structural protein, Glycoprotein, Proteoglycan
01

Overview

The capillary endothelial barrier represents the integrated structural and functional elements that maintain vascular integrity and regulate the passage of substances between the blood and interstitium (Claesson-Welsh et al., 2021). This complex barrier consists of the endothelial glycocalyx, a carbohydrate-rich layer on the luminal surface; the endothelial cell monolayer, characterized by tight and adherens junctions; and the basal lamina (Reitsma et al., 2007). Key proteins such as vascular endothelial cadherin (VE-cadherin) and various claudins are essential for maintaining the paracellular seal (Dejana et al., 2009). In healthy physiology, these components prevent the leakage of plasma proteins and blood cells while allowing for controlled nutrient exchange. In diseases such as sepsis, diabetes, and cancer, these components are often degraded or dysregulated, leading to pathological vascular leakage and tissue edema (Woodfin et al., 2011). Therapeutic interventions target these components by either inhibiting permeabilizing factors like vascular endothelial growth factor (VEGF) or by using stabilizers that reinforce junctional integrity. For example, monoclonal antibodies like bevacizumab reduce permeability by blocking VEGF signaling, while corticosteroids can enhance the expression of junctional proteins. Consequently, these components are vital targets in managing conditions like diabetic macular edema, acute respiratory distress syndrome, and tumor-associated edema.

Other names
Capillary endothelial barrier componentsVascular endothelial barrierEndothelial junctional complexBlood-tissue barrierEndothelial glycocalyx
02

Mechanism of action

Stabilization of endothelial cell-cell junctions (e.g., vascular endothelial cadherin), inhibition of vascular endothelial growth factor (VEGF) signaling, and protection or restoration of the endothelial glycocalyx (Claesson-Welsh et al., 2021; Dejana et al., 2009).

03

Biological functions

Vascular permeability regulationTissue homeostasisLeukocyte traffickingFluid balance
04

Disease associations

SepsisDiabetic retinopathyAcute respiratory distress syndromeCancer metastasisEdemaInflammation
05

Safety considerations

HypertensionThrombosisImpaired wound healingHemorrhage
06

Interacting drugs

Bevacizumab

5 more in the full profile.

07

Biomarkers

Syndecan-1Soluble vascular endothelial cadherinAngiopoietin-2Vascular endothelial growth factorAlbuminuria

Beyond the preview

Go deeper on Capillary endothelial barrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capillary endothelial barrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call